EXM — Exmceuticals Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Annual cashflow statement for Exmceuticals, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2016 June 30th | 2017 June 30th | 2018 June 30th | 2019 June 30th | 2020 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.496 | -0.154 | -0.335 | -9.83 | -9.93 |
| Depreciation | |||||
| Non-Cash Items | 0 | — | -0.004 | 4.89 | 3.94 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.006 | 0.09 | -0.028 | -0.241 | 2.49 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.489 | -0.064 | -0.367 | -5.18 | -3.36 |
| Capital Expenditures | 0 | — | — | -0.813 | -1.1 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | — | -0.25 | -0.669 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | — | -0.25 | -1.48 | -1.1 |
| Financing Cash Flow Items | — | — | -0.007 | 2.6 | -0.009 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.208 | 0.01 | 0.648 | 6.66 | 4.58 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.281 | -0.054 | 0.031 | -0.008 | 0.125 |